A quantitative assessment of glutamate uptake into hippocampal synaptic terminals and astrocytes: new insights into a neuronal role for excitatory amino acid transporter 2 (EAAT2).
The relative distribution of the excitatory amino acid transporter 2 (EAAT2) between synaptic terminals and astroglia, and the importance of EAAT2 for the uptake into terminals is still unresolved. Here we have used antibodies to glutaraldehyde-fixed d-aspartate to identify electron microscopically the sites of d-aspartate accumulation in hippocampal slices. About 3/4 of all terminals in the stratum radiatum CA1 accumulated d-aspartate-immunoreactivity by an active dihydrokainate-sensitive mechanism which was absent in EAAT2 glutamate transporter knockout mice. These terminals were responsible for more than half of all d-aspartate uptake of external substrate in the slices. This is unexpected as EAAT2-immunoreactivity observed in intact brain tissue is mainly associated with astroglia. However, when examining synaptosomes and slice preparations where the extracellular space is larger than in perfusion fixed tissue, it was confirmed that most EAAT2 is in astroglia (about 80%). Neither d-aspartate uptake nor EAAT2 protein was detected in dendritic spines. About 6% of the EAAT2-immunoreactivity was detected in the plasma membrane of synaptic terminals (both within and outside of the synaptic cleft). Most of the remaining immunoreactivity (8%) was found in axons where it was distributed in a plasma membrane surface area several times larger than that of astroglia. This explains why the densities of neuronal EAAT2 are low despite high levels of mRNA in CA3 pyramidal cell bodies, but not why EAAT2 in terminals account for more than half of the uptake of exogenous substrate by hippocampal slice preparations. This and the relative amount of terminal versus glial uptake in the intact brain remain to be discovered.
Furness
D N
DN
Institute of Science and Technology in Medicine, Keele University, Keele, Staffs, ST5 5BG, UK.
Dehnes
Y
Y
Akhtar
A Q
AQ
Rossi
D J
DJ
Hamann
M
M
Grutle
N J
NJ
Gundersen
V
V
Holmseth
S
S
Lehre
K P
KP
Ullensvang
K
K
Wojewodzic
M
M
Zhou
Y
Y
Attwell
D
D
Danbolt
N C
NC
D000818:Animals; D001224:Aspartic Acid / Q000378:metabolism / Q000502:physiology; D001253:Astrocytes / Q000378:metabolism* / Q000648:ultrastructure; D002462:Cell Membrane / Q000378:metabolism / Q000648:ultrastructure; D004591:Electrophoresis, Polyacrylamide Gel; D027342:Excitatory Amino Acid Transporter 2 / Q000235:genetics / Q000502:physiology*; D018698:Glutamic Acid / Q000378:metabolism*; D006624:Hippocampus / Q000166:cytology* / Q000378:metabolism*; D007150:Immunohistochemistry; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D008854:Microscopy, Electron; D016253:Microscopy, Immunoelectron; D009457:Neuroglia / Q000502:physiology; D017729:Presynaptic Terminals / Q000378:metabolism* / Q000502:physiology* / Q000648:ultrastructure; D051381:Rats; D017208:Rats, Wistar; D013379:Substrate Specificity; D013574:Synaptosomes / Q000378:metabolism
D027342:Excitatory Amino Acid Transporter 2; C493395:Slc1a2 protein, rat; D001224:Aspartic Acid; D018698:Glutamic Acid